Fund focus: Genesis targets China's tech inflection points
With $850 million in dry powder to deploy from its second US dollar-denominated fund, China’s Genesis Capital is targeting Series C and D rounds for start-ups on the cusp of greatness
Genesis Capital’s sweet spot is defined by timing, as well as by industry and size: the Chinese growth-stage investor wants to back technology-enabled companies after their products are proven but before...
More on Greater China
Latest News
Portfolio: Capital Square Partners and Aegis/StarTek
Capital Square Partners’ acquisition of Indian business processing outsourcing (BPO) player Aegis ultimately helped two different companies find global relevance after a turbulent and disruptive decade
Indian fintech Juspay raises $21m Series B
Juspay, a developer of mobile payment solutions for online businesses, has raised $21.6 million in a Series B round led by Vostok Emerging Finance, a Swedish investment firm.
Japan mobile banking player gets $45m Series C
Kyash, a Tokyo-based mobile banking start-up, has received $45 million in Series C funding led by Greenspring Associates and Goodwater Capital.
Square Peg joins Series B for Singapore's Doctor Anywhere
Australian VC firm Square Peg Capital has joined a $27 million Series B round for Singapore-based healthcare technology provider Doctor Anywhere.